Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(67%)

Results Posted

0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Detailed Status

Recruiting2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Trials by Status

recruiting267%

completed133%

Recent Activity

2 active trials

Showing 3 of 3

recruiting

A Post-market Prospective Clinical Study of Eurosilicone Luna Mammary Implants

NCT07679594

recruiting

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

NCT07037576

completed

Cost-Effectiveness of Abdominal-based Autogenous Tissue vs Tissue Expander-Implant Reconstruction - A Feasibility Study

NCT02438449

Clinical Trials (3)

Showing 3 of 3 trials

NCT07679594

A Post-market Prospective Clinical Study of Eurosilicone Luna Mammary Implants

Recruiting

NCT07037576

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

Recruiting

NCT02438449

Cost-Effectiveness of Abdominal-based Autogenous Tissue vs Tissue Expander-Implant Reconstruction - A Feasibility Study

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3